Evaluation of the genetic stability of Sabin strains and the consistency of inactivated poliomyelitis vaccine made from Sabin strains using direct deep-sequencing

被引:5
|
作者
Deng, Yan [1 ,2 ,3 ]
Cai, Wei [1 ,2 ,3 ]
Li, Jinyan [1 ,2 ]
Li, Ying [1 ,2 ]
Yang, Xiaolei [1 ,2 ,3 ]
Ma, Yan [1 ,2 ,3 ]
Yao, Yufeng [1 ,2 ]
Yang, Lujie [1 ,2 ,3 ]
Shi, Li [1 ,2 ]
Sun, Mingbo [1 ,2 ,3 ]
机构
[1] Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Yunnan, Peoples R China
[2] Peking Union Med Coll, Kunming 650118, Yunnan, Peoples R China
[3] Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming 650118, Yunnan, Peoples R China
关键词
sIPV; Sabin strain; Direct deep-sequencing; Genetic stability; ORAL POLIOVIRUS VACCINE; NEUROVIRULENCE TEST; READ ALIGNMENT; REGION; GENOME;
D O I
10.1016/j.vaccine.2018.11.020
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Inactivated poliomyelitis vaccine made from Sabin strains (sIPV) has been encouraged to introduce in the "Global Polio Eradication & Endgame Strategic Plan" and increasingly used worldwide. Attenuated Sabin strains used in manufacture of oral poliovirus vaccine (OPV) and sIPV may regain full or partial neurovirulence during growth in vaccine recipients and the vaccine manufacturing processes. Ensuring the molecular consistency of sIPV batches and that no mutation accumulates beyond the level present in past batches are important for quality control of vaccine manufacture process. Direct deep-sequencing allows the construction of a library of virus RNA and the detection of genetic mutations throughout the viral genome. In the present study, direct deep-sequencing was conducted to detect molecular mutations in virus passages, multiple sIPV monovalent lots, and virus monovalent lots from different polio type Ill strains. The results indicated that direct deep-sequencing can be used to identify and quantify small amounts of mutant viruses in vaccine preparations, trace the source of a specific virus seed, and monitor the batch-to-batch consistency of vaccines, suggesting that this technique could be suitable for the quality control and consistency monitoring of sIPV production. (C) 2018 Elsevier Ltd. All rights reserved.
引用
收藏
页码:130 / 136
页数:7
相关论文
共 34 条
  • [1] Antigenic and immunogenic properties of inactivated polio vaccine made from Sabin strains
    Kersten, G
    Hazendonk, T
    Beuvery, C
    VACCINE, 1999, 17 (15-16) : 2059 - 2066
  • [2] Development of inactivated poliovirus vaccine derived from Sabin strains
    Simizu, B
    Abe, S
    Yamamoto, H
    Tano, Y
    Ota, Y
    Miyazawa, M
    Horie, H
    Satoh, K
    Wakabayashi, K
    BIOLOGICALS, 2006, 34 (02) : 151 - 154
  • [3] Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strains
    Verdijk, Pauline
    Rots, Nynke Y.
    Bakker, Wilfried A. M.
    EXPERT REVIEW OF VACCINES, 2011, 10 (05) : 635 - 644
  • [4] Immunogenicity of fractional-dose of inactivated poliomyelitis vaccine made from Sabin strains delivered by intradermal vaccination in Wistar rats
    Ma, Yan
    Ying, Zhifang
    Li, Jingyan
    Gu, Qin
    Wang, Xiaoyu
    Cai, Lukui
    Shi, Li
    Sun, Mingbo
    BIOLOGICALS, 2022, 75 : 3 - 11
  • [5] Immunogenicity and safety of the inactivated poliomyelitis vaccine made from Sabin strains in a phase IV clinical trial for the vaccination of a large population
    Jiang, Ruiju
    Liu, Xiaoqiang
    Sun, Xiaodong
    Wang, Jianfeng
    Huang, Zhuoying
    Li, Changgui
    Li, Zhi
    Zhou, Jianmei
    Pu, Yi
    Ying, Zhifang
    Yin, Qiongzhou
    Zhao, Zhimei
    Zhang, Lifeng
    Lei, Jing
    Bao, Wenmei
    Jiang, Ya
    Dou, Youjian
    Li, Jingyu
    Yang, Haitao
    Cai, Wei
    Deng, Yan
    Che, Yanchun
    Shi, Li
    Sun, Mingbo
    VACCINE, 2021, 39 (09) : 1463 - 1471
  • [6] Development of inactivated poliovirus vaccine from Sabin strains: A progress report
    Okayasu, Hiromasa
    Sein, Carolyn
    Hamidi, Ahd
    Bakker, Wilfried A. M.
    Sutter, Roland W.
    BIOLOGICALS, 2016, 44 (06) : 581 - 587
  • [7] Safety evaluation on concomitant immunization with inactivated poliomyelitis vaccine produced from Sabin strains and other vaccines (from 2015 to 2020)
    Deng, Yan
    Yi, Li
    Li, Ying
    Zhao, Zhimei
    Zhong, Zhilei
    Shi, Haoyu
    Li, Jiarong
    Liang, Yan
    Yang, Jingsi
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01)
  • [8] Development of Inactivated Polio Vaccine (IPV) Derived from Attenuated Sabin Strains
    Bakker, Wilfried A. M.
    Thomassen, Yvonne E.
    van 't Oever, Aart G.
    Westdijk, Janny
    van Oijen, Monique G. C. T.
    Kersten, Gideon F. A.
    van der Pol, Leo A.
    Hertroys, Rudy
    van den Heuvel, Nico
    Hendriks, Jan
    PROCEEDINGS OF THE 21ST ANNUAL MEETING OF THE EUROPEAN SOCIETY FOR ANIMAL CELL TECHNOLOGY (ESACT), 2009, 2012, 5 : 667 - 670
  • [9] VACCINATION OF ADULTS WITH A BRITISH ORAL POLIOMYELITIS VACCINE PREPARED FROM SABIN STRAINS
    GOFFE, A
    SHAND, FL
    POLLOCK, TM
    BRITISH MEDICAL JOURNAL, 1961, 2 (524): : 272 - &
  • [10] A national reference for inactivated polio vaccine derived from Sabin strains in Japan
    Shirato, Haruko
    Someya, Yuichi
    Ochiai, Masaki
    Horiuchi, Yoshinobu
    Takahashi, Motohide
    Takeda, Naokazu
    Wakabayashi, Kengo
    Ouchi, Yasumitsu
    Ota, Yoshihiro
    Tano, Yoshio
    Abe, Shinobu
    Yamazaki, Shudo
    Wakita, Takaji
    VACCINE, 2014, 32 (40) : 5163 - 5169